The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improving the prediction of surgical outcome at secondary cytoreduction in patients with ovarian cancer: Results from retrospective part of HELP-ER study NOGGO TR2/ENGOT OV47-TR.
 
Ioana Braicu
Honoraria - Abbvie; AstraZeneca; Clovis Oncology; Roche; Roche; Tesaro; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Tesaro/GSK
Research Funding - AstraZeneca (Inst); Bayer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Clovis Oncology; Roche; Tesaro
 
Wanja Nikolai Kassuhn
No Relationships to Disclose
 
Hagen Kulbe
No Relationships to Disclose
 
Pauline Wimberger
Honoraria - Amgen; AstraZeneca; Eisai; MSD Oncology; Novartis/Pfizer; Pfizer; Roche Pharma AG; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Novartis; PharmaMar; Roche Pharma AG; Tesaro
Travel, Accommodations, Expenses - Roche Pharma AG
 
Cagatay Taskiran
No Relationships to Disclose
 
Klaus Pietzner
Honoraria - AstraZeneca; Clovis Oncology; MSD; Roche; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; MSD; Roche; Tesaro/GSK
 
Alexander Mustea
Consulting or Advisory Role - Roche; Tesaro/GSK
Speakers' Bureau - MSD
Travel, Accommodations, Expenses - Intuitive Surgical
 
Robert Armbrust
Travel, Accommodations, Expenses - Roche
 
J.P. P. Grabowski
Honoraria - AstraZeneca; Clovis Oncology; RIEMSER; Tesaro; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Tesaro; Tesaro/GSK
Speakers' Bureau - AstraZeneca; Clovis Oncology; RIEMSER; Tesaro; Tesaro/GSK
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Institut Allergosan (Inst); MSD (Inst); RIEMSER (Inst); Tesaro (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - Tesaro/GSK
 
Felix Schmidt
No Relationships to Disclose
 
Ali Ayhan
No Relationships to Disclose
 
Carmen Rosa Beteta
No Relationships to Disclose
 
Christina Fotopoulou
Honoraria - AstraZeneca; Clovis Oncology; Ethicon; MSD; Roche; Sequana Medical; Tesaro; Tesaro/GSK
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro